MCM
M28 Capital Management Portfolio holdings
AUM
$58.6M
This Quarter Return
+32.33%
1 Year Return
+32.71%
3 Year Return
+247.5%
5 Year Return
–
10 Year Return
–
AUM
$102M
AUM Growth
+$102M
(+12%)
Cap. Flow
-$5.88M
Cap. Flow
% of AUM
-5.77%
Top 10 Holdings %
Top 10 Hldgs %
98.76%
Holding
11
New
–
Increased
1
Reduced
1
Closed
–
Top Buys
| 1 |
Curis
CRIS
|
$303K |
Top Sells
| 1 |
Wave Life Sciences
WVE
|
$6.19M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Wave Life Sciences
WVE
$1.53B
| $70.1M | 68.79% | 5,664,548 -500,000 | -8% | -$6.19M |
|
2
TG Therapeutics
TGTX
$4.65B
| $4.86M | 4.78% | 161,600 | – | – |
|
3
Rocket Pharmaceuticals
RCKT
$354M
| $4.85M | 4.76% | 385,680 | – | – |
|
4
Invivyd
IVVD
$204M
| $4.1M | 4.02% | 9,248,250 | – | – |
|
|
SWTX
5
DELISTED
SpringWorks Therapeutics
SWTX
| $3.99M | 3.92% | 110,400 | – | – |
|
6
Fractyl Health
GUTS
$68.8M
| $3.82M | 3.75% | 1,856,117 | – | – |
|
7
BridgeBio Pharma
BBIO
$9.89B
| $3.33M | 3.27% | 121,200 | – | – |
|
8
ProQR Therapeutics
PRQR
$237M
| $2.7M | 2.65% | 1,019,498 | – | – |
|
|
9
Curis
CRIS
$20.9M
| $1.59M | 1.57% | 521,059 +99,108 | +23% | +$303K |
|
|
SLN
10
Silence Therapeutics
SLN
$227M
| $1.27M | 1.25% | 185,100 | – | – |
|
11
Arrowhead Research
ARWR
$3.05B
| $1.27M | 1.24% | 67,400 | – | – |
|